High-Density Lipoproteins: Metabolism and Protective Roles Against Atherosclerosis

Biochemistry of Lipids, Lipoproteins and Membranes: Sixth Edition

Volumn , Issue , 2016, Pages 437-457

  Francis, Gordon A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ABCA1; ABCG1; Apolipoproteins; CETP; Cholesterol efflux; High density lipoproteins (HDLs); LCAT; PTLP; Reverse cholesterol transport; SR BI

Indexed keywords

EID: 85018193547     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-63438-2.00015-8     Document Type: Chapter

References (45)

1. Adorni M.P., Zimetti F., Billheimer J.T., Wang N., Rader D.J., Phillips M.C., Rothblat G.H. The roles of different pathways in the release of cholesterol from macrophages. J. Lipid Res. 2007, 48:2453-2462.
2. Asztalos B.F., Brousseau M.E., Mcnamara J.R., Horvath K.V., Roheim P.S., Schaefer E.J. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis 2001, 156:217-225.
3. Barr D.P., Russ E.M., Eder H.A. Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions. Am. J. Med. 1951, 11:480-493.
4. Barter P.J., Kastelein J.J. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease. J. Am. Coll. Cardiol. 2006, 47:492-499.
5. Bowden K.L., Bilbey N.J., Bilawchuk L.M., Boadu E., Sidhu R., Ory D.S., Du H., Chan T., Francis G.A. Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease. J. Biol. Chem. 2011, 286:30624-30635.
6. Bowry V.W., Stanley K.K., Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. USA 1992, 89:10316-10320.
7. Brunzell J.D., Zambon A., Deeb S.S. The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim. Biophys. Acta 2012, 1821:365-372.
8. Charles M.A., Kane J.P. New molecular insights into CETP structure and function: a review. J. Lipid Res. 2012, 53:1451-1458.
9. Day J.R., Albers J.J., Lofton-Day C.E., Gilbert T.L., Ching A.F., Grant F.J., O'hara P.J., Marcovina S.M., Adolphson J.L. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J. Biol. Chem. 1994, 269:9388-9391.
10. Feig J.E., Rong J.X., Shamir R., Sanson M., Vengrenyuk Y., Liu J., Rayner K., Moore K., Garabedian M., Fisher E.A. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc. Natl. Acad. Sci. USA 2011, 108:7166-7171.
11. Fielding C.J., Fielding P.E. Dynamics of lipoprotein transport in the circulatory system. Biochemistry of Lipids, Lipoproteins and Membranes 2008, Elsevier, Amsterdam. D.E. Vance, J.E. Vance (Eds.).
12. Francis G.A. The complexity of HDL. Biochim. Biophys. Acta 2010, 1801:1286-1293.
13. Francis G.A., Knopp R.H., Oram J.F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J. Clin. Invest. 1995, 96:78-87.
14. Fryirs M.A., Barter P.J., Appavoo M., Tuch B.E., Tabet F., Heather A.K., Rye K.A. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb. Vasc. Biol. 2010, 30:1642-1648.
15. Gao X., Yuan S., Jayaraman S., Gursky O. Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL. Biochemistry 2012, 51:4633-4641.
16. Guo L., Ai J., Zheng Z., Howatt D.A., Daugherty A., Huang B., Li X.A. High density lipoprotein protects against polymicrobe-induced sepsis in mice. J. Biol. Chem. 2013, 288:17947-17953.
17. Huang R., Silva R.A., Jerome W.G., Kontush A., Chapman M.J., Curtiss L.K., Hodges T.J., Davidson W.S. Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma. Nat. Struct. Mol. Biol. 2011, 18:416-422.
18. Jahangiri A., Rader D.J., Marchadier D., Curtiss L.K., Bonnet D.J., Rye K.A. Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I. J. Lipid Res. 2005, 46:896-903.
19. Jonas A., Phillips M.C. Lipoprotein structure. Biochemistry of Lipids, Lipoproteins and Membranes 2008, Elsevier, New York. fifth ed. D.E. Vance, J.E. Vance (Eds.).
20. Kozarsky K.F., Donahee M.H., Rigotti A., Iqbal S.N., Edelman E.R., Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997, 387:414-417.
21. Kunnen S., Van Eck M. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?. J. Lipid Res. 2012, 53:1783-1799.
22. Lund-Katz S., Phillips M.C. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell. Biochem. 2010, 51:183-227.
23. Lyssenko N.N., Nickel M., Tang C., Phillips M.C. Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability. FASEB J. 2013, 27:2880-2892.
24. Mineo C., Shaul P.W. Novel biological functions of high-density lipoprotein cholesterol. Circ. Res. 2012, 111:1079-1090.
25. Oram J.F., Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 2005, 85:1343-1372.
26. Oram J.F., Wolfbauer G., Tang C., Davidson W.S., Albers J.J. An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux. J. Biol. Chem. 2008, 283:11541-11549.
27. Ouimet M., Franklin V., Mak E., Liao X., Tabas I., Marcel Y.L. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab. 2011, 13:655-667.
28. Phillips M.C. Molecular mechanisms of cellular cholesterol efflux. J. Biol. Chem. 2014, 289:24020-24029.
29. Qiu X., Mistry A., Ammirati M.J., Chrunyk B.A., Clark R.W., Cong Y., Culp J.S., Danley D.E., Freeman T.B., Geoghegan K.F., Griffor M.C., Hawrylik S.J., Hayward C.M., Hensley P., Hoth L.R., Karam G.A., Lira M.E., Lloyd D.B., Mcgrath K.M., Stutzman-Engwall K.J., Subashi A.K., Subashi T.A., Thompson J.F., Wang I.K., Zhao H., Seddon A.P. Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules. Nat. Struct. Mol. Biol. 2007, 14:106-113.
30. Rader D.J., Degoma E.M. Approach to the patient with extremely low HDL-cholesterol. J. Clin. Endocrinol. Metab. 2012, 97:3399-3407.
31. Rohatgi A., Khera A., Berry J.D., Givens E.G., Ayers C.R., Wedin K.E., Neeland I.J., Yuhanna I.S., Rader D.R., De Lemos J.A., Shaul P.W. HDL cholesterol efflux capacity and incident cardiovascular events. N. Engl. J. Med. 2014, 317:2383-2393.
32. Rye K.A., Barter P.J. Cardioprotective functions of HDLs. J. Lipid Res. 2014, 55:168-179.
33. Segrest J.P., Jones M.K., Klon A.E., Sheldahl C.J., Hellinger M., De Loof H., Harvey S.C. A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J. Biol. Chem. 1999, 274:31755-31758.
34. Serfaty-Lacrosniere C., Civeira F., Lanzberg A., Isaia P., Berg J., Janus E.D., Smith M.P., Pritchard P.H., Frohlich J., Lees R.S., et al. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 1994, 107:85-98.
35. Settasatian N., Duong M., Curtiss L.K., Ehnholm C., Jauhiainen M., Huuskonen J., Rye K.A. The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J. Biol. Chem. 2001, 276:26898-26905.
36. Skipski V.R. Lipid composition of lipoproteins in normal and diseased states. Blood Lipids and Lipoproteins: Quantitation, Composition, and Metabolism 1972, Wiley-Interscience, New York. G.J. Nelson (Ed.).
37. Tabet F., Vickers K.C., Cuesta Torres L.F., Wiese C.B., Shoucri B.M., Lambert G., Catherinet C., Prado-Lourenco L., Levin M.G., Thacker S., Sethupathy P., Barter P.J., Remaley A.T., Rye K.A. Hdl-transferred microRNA-223 regulates Icam-1 expression in endothelial cells. Nat. Commun. 2014, 5:3292.
38. Tanigawa H., Billheimer J.T., Tohyama J., Fuki I.V., Ng D.S., Rothblat G.H., Rader D.J. Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo. Circulation 2009, 120:160-169.
39. Vaisar T. Proteomics investigations of HDL: challenges and promise. Curr. Vasc. Pharmacol. 2012, 10:410-421.
40. Vaisar T., Pennathur S., Green P.S., Gharib S.A., Hoofnagle A.N., Cheung M.C., Byun J., Vuletic S., Kassim S., Singh P., Chea H., Knopp R.H., Brunzell J., Geary R., Chait A., Zhao X.Q., Elkon K., Marcovina S., Ridker P., Oram J.F., Heinecke J.W. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 2007, 117:746-756.
41. Vergeer M., Korporaal S.J., Franssen R., Meurs I., Out R., Hovingh G.K., Hoekstra M., Sierts J.A., Dallinga-Thie G.M., Motazacker M.M., Holleboom A.G., Van Berkel T.J., Kastelein J.J., Van Eck M., Kuivenhoven J.A. Genetic variant of the scavenger receptor BI in humans. N. Engl. J. Med. 2011, 364:136-145.
42. Wu Z., Gogonea V., Lee X., May R.P., Pipich V., Wagner M.A., Undurti A., Tallant T.C., Baleanu-Gogonea C., Charlton F., Ioffe A., Didonato J.A., Rye K.A., Hazen S.L. The low resolution structure of ApoA1 in spherical high density lipoprotein revealed by small angle neutron scattering. J. Biol. Chem. 2011, 286:12495-12508.
43. Yvan-Charvet L., Pagler T., Gautier E.L., Avagyan S., Siry R.L., Han S., Welch C.L., Wang N., Randolph G.J., Snoeck H.W., Tall A.R. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010, 328:1689-1693.
44. Yvan-Charvet L., Wang N., Tall A.R. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb. Vasc. Biol. 2010, 30:139-143.
45. Zhang L., Yan F., Zhang S., Lei D., Charles M.A., Cavigiolio G., Oda M., Krauss R.M., Weisgraber K.H., Rye K.A., Pownall H.J., Qiu X., Ren G. Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. Nat. Chem. Biol. 2012, 8:342-349.